Creating sustainable supply chains

The specific problem we are working to solve is the inefficiency and environmental impact of rare disease healthcare, which affects approximately 10% of the population. The current diagnostic journey for rare disease patients is costly, time-consuming, and resource-intensive, leading to significant waste and redundancies in biomedical research funding. By creating sustainable supply chains and implementing closed loop product development, we aim to decrease the carbon footprint of rare disease healthcare while improving efficiency and reducing environmental costs. This solution directly addresses factors contributing to the problem, such as the excessive use of single-use products, unnecessary plastics, and medical/hazardous waste throughout research and manufacturing. By optimizing transportation and promoting alternative packaging, we can also minimize shipping inefficiencies, cold storage challenges, and last-mile delivery issues.

Our solution is a mobile application designed specifically for rare disease families. It serves as a comprehensive tool to support and empower individuals and their caregivers throughout their healthcare journey. The mobile app utilizes technology to provide accessible and user-friendly features, tailored to the unique needs of rare disease patients.

Key features of our mobile application include:

1. Information and Resources: The app provides a centralized platform where rare disease families can access reliable information, educational resources, and support networks. It offers a vast library of articles, videos, and expert insights to help users better understand their condition and navigate the healthcare system.

2. Symptom Tracking and Management: Users can track and manage symptoms and health-related data through intuitive interfaces. The app allows individuals to monitor their condition, log medications, record vitals, and track any changes in symptoms. This data can be shared with healthcare providers, enabling more informed and personalized care.

3. Appointment and Medication Reminders: The app sends reminders for upcoming medical appointments, medication schedules, and refills. This feature helps users stay organized and ensures they never miss an important appointment or dose, leading to improved adherence and better health outcomes.

4. Community and Support: The app facilitates connections with other rare disease families, creating a supportive community where individuals can share experiences, seek advice, and find emotional support. It also connects users with patient advocacy groups and local resources to enhance their support network.

The mobile application works on various devices such as smartphones and tablets. It leverages user-friendly interfaces, intuitive navigation, and a visually appealing design to provide a seamless user experience. The app integrates with existing healthcare systems, allowing for data sharing with healthcare providers and enabling personalized care plans.

For the sustainable supply chain, my solution is glass.

Glass can be a sustainable resource that contributes to a sustainable supply chain for the supply of medicines for rare diseases. Here's how glass can support sustainability in the context of rare disease healthcare:

1. Reusability: Glass containers, such as vials or bottles, can be reused multiple times, reducing the need for single-use packaging. This helps minimize the amount of waste generated during the manufacturing and distribution of medicines for rare diseases.

2. Recyclability: Glass is highly recyclable, and it can be processed into new glass products without losing its quality or properties. Incorporating recycled glass into the production of packaging materials promotes a circular economy and reduces the demand for virgin materials.

3. Safety and preservation: Glass containers provide excellent protection for medicines. They are impermeable to gases and moisture, ensuring the integrity and stability of the medications. This reduces the risk of product degradation, thereby minimizing waste resulting from ineffective or expired medicines.

4. Environmental impact: Compared to plastic or other packaging materials, glass has a lower environmental impact. It is made from natural materials such as sand, soda ash, and limestone, which are abundant and renewable. Additionally, glass manufacturing processes typically have a smaller carbon footprint compared to plastic production.

Our solution serves the population affected by rare diseases, specifically targeting those individuals and their caregivers whose lives can be directly and meaningfully improved. Rare disease patients face unique challenges in terms of diagnosis, treatment, and overall healthcare experience. By understanding their needs and engaging them throughout the development of our solution, we aim to create a solution that effectively addresses their specific requirements.

To understand the needs of rare disease patients, we are actively involving them in the development process through patient-centered design approaches. We conduct interviews, surveys, and focus groups with patients, caregivers, and advocacy groups to gain insights into their experiences, challenges, and priorities. By listening to their perspectives, we ensure that our solution aligns with their needs and preferences.

Our engagement with the target population goes beyond data collection. We collaborate with patient advocacy organizations, support groups, and healthcare professionals specializing in rare diseases to foster ongoing dialogue and gather diverse perspectives. This collaborative approach enables us to co-create the solution with the input and guidance of those directly affected.

The developed solution will address the needs of rare disease patients by:

1. Streamlining the diagnostic journey: By improving efficiency, reducing time, cost, resources, and unnecessary travel and testing, we aim to minimize the burdensome diagnostic process for patients and caregivers. This will expedite access to accurate diagnoses and facilitate timely treatment initiation.

2. Enhancing clinical trials and research: Our solution focuses on optimizing data collection and sharing, allowing researchers and healthcare providers to collaborate more effectively. By reducing redundancies and improving the efficiency of clinical trials and research, we can accelerate the development of new treatments and interventions for rare diseases.

3. Promoting sustainability and environmental responsibility: Through sustainable supply chains and closed loop product development, our solution addresses the environmental costs associated with rare disease healthcare. By decreasing waste, reducing the use of single-use products and unnecessary plastics, and optimizing transportation logistics, we contribute to a more sustainable and eco-friendly approach to healthcare delivery.

Our team is uniquely positioned to design and deliver this solution to the target population of individuals with rare diseases. What sets us apart is our deep understanding of the communities we serve and our firsthand experience in building blockchain-based mobile applications for local businesses.

As the Team Lead, I have gained valuable insights into consumer behavior and the importance of sustainable supply chains through my experience in running my own supermarket. This experience has provided me with a practical understanding of the challenges faced by businesses and the need for innovative solutions that address the needs of both consumers and the environment.

Our team also actively engages with the rare disease community to understand their specific needs and challenges. We have established partnerships with patient advocacy groups, healthcare providers, and rare disease organizations. Through these collaborations, we conduct regular focus groups, interviews, and surveys to gather feedback and insights directly from the target population.

The design and implementation of our solution are meaningfully guided by the input, ideas, and agendas of the rare disease community. We believe in co-creation and involve community members in the development process through participatory design workshops and user testing sessions. This ensures that the app truly reflects the needs, preferences, and priorities of the end-users.

Furthermore, our team is well-versed in leveraging blockchain technology to create secure and transparent solutions. Building on our experience in developing blockchain-based applications for local businesses, we understand the potential of this technology to enhance data privacy, enable secure transactions, and foster trust within the healthcare ecosystem. By incorporating blockchain into our solution, we can provide a robust and reliable platform for rare disease families to manage their health information and engage with healthcare providers.

In summary, our team's proximity to the communities we serve, combined with our experience in building blockchain-based mobile applications for local businesses and my firsthand understanding of consumer psyche and sustainable supply chains, positions us well to design and deliver a solution that truly meets the needs of individuals with rare diseases. We are committed to actively engaging with the community, listening to their voices, and incorporating their insights throughout the development process to ensure that our solution is relevant, effective, and truly impactful.

We have also built a complete patient management system for the Gracias Maternity Clinic, which has given us a lot of insight into how patients interact with such a system.

We are applying because we believe it presents a valuable opportunity to further our mission of transforming the perception of hospitals in rural India and improving access to healthcare for individuals in these communities. Specifically, we hope this competition can help us overcome various financial, technical, legal, cultural, and market barriers that currently limit healthcare access and contribute to the negative perception of hospitals. 

Financial Barrier: One major challenge we face is limited financial resources to scale our solution and reach a larger population. Participating in this competition provides us with the potential to secure funding and investment opportunities that can support the expansion of our solution and enable us to reach more individuals in rural India.

Technical Barrier: Developing and implementing a mobile application tailored to the needs of rural communities requires advanced technical expertise and infrastructure. By participating in this competition, we can gain exposure to technical resources, mentorship, and potential partnerships that can enhance our technical capabilities and help overcome the existing technical barriers.

Legal Barrier: Legal frameworks and regulatory processes can pose challenges in the healthcare sector, particularly when it comes to data privacy and security. Engaging in this competition can provide us with access to legal expertise and guidance, enabling us to navigate these barriers effectively and ensure compliance with relevant regulations.

Cultural Barrier: Cultural perceptions and beliefs play a significant role in shaping the acceptance and utilization of healthcare services, especially in rural areas. Through this competition, we hope to gain visibility and recognition that can help challenge and change negative perceptions of hospitals. By highlighting the positive impact our solution has on the lives of individuals, we aim to shift cultural attitudes towards seeking medical treatment, ultimately leading to more people being treated and living better lives.

Market Barrier: The healthcare market in rural India can be complex and fragmented, with limited infrastructure and access to services. This competition can provide us with a platform to showcase our solution and connect with potential partners, investors, and stakeholders who can help us navigate the market barriers. By establishing strategic collaborations, we can leverage existing networks and resources to expand our reach and create a more sustainable and impactful healthcare model in rural India.

In summary, we are applying to this competition because we believe it can help us overcome financial, technical, legal, cultural, and market barriers that hinder access to healthcare in rural India. By addressing these barriers, we aim to change the perception of hospitals and inspire more people in rural communities to seek treatment, ultimately enabling them to live better lives with improved health outcomes.

As Team Lead, Miguel Souza is a native of the state of Goa in India, with over five generations publicly recorded in the archives. Some of the leading doctors are directly related to him, for example his great grand father Pedro Leao de Barros, whose writings are still available online http://memoria-africa.ua.pt/Li...

His mother was a nurse at the Tata Cancer hospital, so those experiences are equally fresh in his mind, as stories told from the time he could understand English.

Our solution is innovative and sustainable in several key ways, enabling us to approach the problem of rare disease healthcare in a new and improved manner. Here's how our solution stands out:

1. Technological Innovation: Our use of mobile app and blockchain technology introduces a novel approach to streamline the diagnostic journey, enhance data sharing, and engage patients in their healthcare. By leveraging these technologies, we can create a seamless and efficient platform that improves access, reduces wastage, and empowers patients.

2. Patient-Centric Focus: Our solution places the patient at the center of the rare disease healthcare journey. We prioritize understanding and addressing the unique needs, challenges, and preferences of patients and caregivers. By providing personalized guidance, symptom tracking, and educational resources, we empower patients to take an active role in managing their health.

3. Sustainable Supply Chains: We tackle environmental sustainability by promoting sustainable supply chains and closed-loop product development. By reducing single-use products, unnecessary plastics, and medical waste, we minimize the ecological footprint of rare disease healthcare. Our solution catalyzes positive impacts by inspiring others in the healthcare space to adopt similar sustainable practices and contribute to a greener industry.

4. Collaboration and Ecosystem Building: We foster collaboration among key stakeholders including patient advocacy groups, healthcare providers, and research institutions. By building partnerships, we create a network of support and knowledge-sharing, catalyzing broader positive impacts. Our solution has the potential to change the market by setting a precedent for patient-centric, sustainable approaches to rare disease healthcare, driving industry-wide shifts towards more efficient and environmentally conscious practices.

5. Scalability and Global Impact: Our solution is designed to scale and reach a broad population of rare disease patients globally. By leveraging technology and data-driven insights, we can adapt our solution to different regions and healthcare systems, making a meaningful impact on a larger scale.

Overall, our innovative use of technology, patient-centric approach, focus on sustainability, collaboration, and scalability set us apart. By catalyzing positive impacts and inspiring change within the rare disease healthcare space, our solution has the potential to drive broader industry transformations, improving outcomes for patients, reducing waste, and promoting sustainable practices.

Our impact goals for the next year and the next five years are centered around transforming the perception of medical services from a one way street to an end to pain and sickness. We aim to create a profound shift in how people experience healthcare and empower them to live healthier and more fulfilling lives. Here's how we plan to achieve these impact goals:

1. Enhancing Patient-Centric Care: We will continue to prioritize patient-centric care by expanding the features and functionalities of our mobile application. This includes providing personalized health management tools, access to reliable information, and fostering a supportive community. By empowering individuals with rare diseases to actively participate in their care and make informed decisions, we aim to shift the narrative from hopelessness to empowerment.

2. Improving Health Outcomes: We will measure the impact of our solution by tracking and analyzing key health outcomes of rare disease patients using the app. This includes indicators such as symptom management, medication adherence, and overall quality of life. By monitoring these metrics, we can assess the effectiveness of our solution and make continuous improvements to enhance health outcomes.

3. Advocacy and Awareness: We will actively engage in advocacy efforts to raise awareness about rare diseases and the unique challenges faced by individuals living with them. Through partnerships with patient advocacy groups, healthcare organizations, and awareness campaigns, we aim to foster a broader understanding and empathy within society. This increased awareness can help change the perception of medical services and create a more supportive and inclusive environment for rare disease patients.

4. Collaborations and Partnerships: We will seek collaborations and partnerships with healthcare providers, researchers, and policymakers to drive systemic changes in the healthcare landscape. By working together, we can advocate for policy reforms, promote research initiatives, and influence the integration of patient-centric approaches in healthcare systems. This collaboration will contribute to our overarching goal of transforming medical services into a pathway towards healing and improved quality of life.

5. Scalability and Global Reach: Over the next five years, we aim to expand the reach of our solution globally, ensuring that individuals with rare diseases from diverse communities can benefit from our app. By scaling our impact, we can touch the lives of a larger population, challenge societal perceptions, and inspire a broader movement towards redefining medical services as a source of hope and healing.

Through these concerted efforts, we aim to achieve a significant transformation in how people perceive medical services. By shifting the focus from the despair of illness to the potential for healing, our impact goals seek to improve the lives of individuals with rare diseases and empower them to live with hope, resilience, and a sense of purpose.

Our solution contributes to achieving Target 9.1 of the UN Sustainable Development Goals (SDGs) by developing quality, reliable, sustainable, and resilient infrastructure to support economic development and human well-being, with a focus on affordable and equitable access for all. Here's how we measure our progress toward this impact goal:

1. Infrastructure Accessibility: We track the number of rare disease patients who have improved access to healthcare infrastructure through our solution. This includes measuring the increase in the availability of diagnostic facilities, clinical trial centers, and specialist expertise in regions where access was previously limited.

2. Affordability: We assess the affordability aspect by monitoring the cost savings achieved by patients and caregivers through reduced travel, testing, and unnecessary medical expenses. We measure the financial impact on individuals and families, ensuring that our solution promotes affordable access to healthcare services.

3. Equity: To measure equity, we evaluate the distribution of our solution's benefits across different demographics, socioeconomic backgrounds, and geographic regions. We track the percentage of underserved communities and disadvantaged populations that gain improved access to healthcare infrastructure, ensuring that our solution narrows the gap in healthcare disparities.

4. Sustainability and Resilience: We gauge the sustainability and resilience of our solution by assessing the reduction in environmental impact, such as carbon emissions, waste generation, and plastic usage. We monitor improvements in the efficiency of supply chains, reduction in single-use products, and the adoption of alternative packaging to promote a more sustainable and eco-friendly approach to healthcare.

Additionally, we align our progress measurements with relevant SDG indicators, such as SDG 3.8 (universal health coverage), SDG 9.1 (infrastructure development), and SDG 12.5 (waste reduction and recycling). By aligning our progress indicators with the SDGs, we demonstrate our commitment to achieving broader sustainable development outcomes.

By tracking and analyzing these specific indicators, we can assess the effectiveness of our solution in developing infrastructure that is quality-driven, reliable, sustainable, and resilient. This measurement framework allows us to monitor our progress, make data-driven improvements, and ensure that our solution contributes to the SDG target of affordable and equitable access to healthcare infrastructure for all.

Our solution aims to have a significant impact on reducing wastage and ensuring timely access to healthcare for rare disease patients. The following is a simplified explanation of how and why we expect our solution to achieve this:

1. Activities: We develop a mobile app and blockchain-based platform that streamlines the diagnostic journey, enhances clinical trials and research, and promotes patient engagement.

2. Outputs: Through the app, patients and caregivers can access personalized guidance, symptom tracking tools, and medical record management features. Researchers and healthcare providers can efficiently collect and share data, while patients engage with educational resources and connect with support networks.

3. Immediate Outcomes: By optimizing the diagnostic journey, our solution reduces time, cost, resources, and duplicative travel and testing for patients and caregivers. This leads to quicker and more accurate diagnoses, avoiding unnecessary delays and medical waste. Improved data collection and sharing in clinical trials and research enhance efficiency, accelerate insights, and reduce redundancies.

4. Longer-Term Outcomes: As a result of our solution, we expect to achieve several positive outcomes:

   a. Reduced Wastage: By streamlining the diagnostic process and improving research efficiency, we minimize unnecessary tests, treatments, and resources. This directly reduces wastage in terms of time, money, and medical supplies.

   b. Timely Access to Healthcare: Through efficient diagnostics, patients receive timely diagnoses, enabling prompt treatment initiation. This reduces delays in accessing appropriate care and prevents the progression of rare diseases, potentially leading to better health outcomes for patients.

   c. Improved Resource Allocation: By optimizing the use of resources, including funding, personnel, and medical supplies, our solution ensures that they are allocated more effectively. This allows research and development investments to go further, resulting in more treatments and interventions for rare disease patients.

You can see the number of patients who have increased for the Gracias Maternity clinic, as an example of the amount of change, which our system has created in the rural state of Goa.

Our solution is powered by a combination of mobile application (app) and blockchain technology. The core technology components work together to provide a robust and innovative platform for addressing the challenges in rare disease healthcare. Here's a response based on that premise:

The mobile application serves as the user interface, providing a user-friendly platform for rare disease patients, caregivers, and healthcare professionals to access and interact with various features and services. The app is designed to streamline the diagnostic journey, enhance clinical trials and research, and facilitate patient engagement.

Key features of the mobile app include:

1. Diagnostic Journey Optimization: The app provides personalized guidance, symptom tracking, and medical record management tools to support efficient and cost-effective diagnostic processes. It minimizes duplicative travel and testing, reduces time and resource requirements, and empowers patients and caregivers to actively participate in their healthcare journey.

2. Clinical Trial and Research Enhancement: The app enables seamless data collection and sharing among patients, researchers, and healthcare providers. It facilitates efficient recruitment and participation in clinical trials, accelerates research insights, and supports collaboration across different stakeholders. This technology-driven approach enhances the efficiency and impact of clinical trials and research efforts.

3. Patient Engagement and Empowerment: Through the app, patients and caregivers can access educational resources, connect with support networks, and engage in community forums. It promotes patient-centered care, empowers individuals with rare diseases by providing them with valuable information and resources, and fosters a sense of belonging within the rare disease community.

The blockchain technology forms the underlying infrastructure of our solution, providing secure and decentralized data storage, transparency, and trust. It ensures the integrity and privacy of sensitive health data while enabling data interoperability and accessibility across various stakeholders. Blockchain technology enables secure sharing of anonymized data for research purposes, enhances data security and patient privacy, and ensures the integrity of clinical trial data.

By leveraging app and blockchain technology, our solution revolutionizes rare disease healthcare by providing an innovative, user-centered platform that optimizes diagnostics, enhances research, and empowers patients. This tech-based approach drives efficiency, transparency, and collaboration, ultimately improving outcomes and quality of life for individuals affected by rare diseases.

We have around five people on the team, where one person has been driving the software development side.

Our team and organization have been working on our solution for approximately 7 years. The journey began in June 2016, when we initiated the groundwork and research for developing an innovative approach to address the challenges in rare disease healthcare starting with our work for the Gracias Maternity Clinic. Our organization was officially established and became operational in August 2016, marking the beginning of our dedicated efforts to create a sustainable solution. Over the years, we have continuously refined and improved our solution, leveraging technological advancements, engaging with stakeholders, and adapting to the evolving needs of the rare disease community.

Our approach to diversity is that everyone is welcome, irrespective of sex, religion or caste, purely merit based. Over 50% of our team are women and over three religions are represented.

We focus only on local resources, so locally inclusive. 

In terms of equity, everyone has an equal share in the work, so with every project the company gets, the entire team profits from it.

Our business model has been B2B, where we have been building solutions for institutions such as hospitals.  It would be better to tie up with a pharmaceutical manufacturer as we would then really be in the supply chain and aid them in being more sustainable and effective to their communities.

Our plan for becoming financially sustainable involves leveraging our solution by licensing it to pharmaceutical companies. This approach allows us to generate revenue streams that can cover our expected expenses and support the ongoing development and maintenance of our solution. By licensing our solution, we establish partnerships with pharmaceutical companies who can benefit from the innovative features and capabilities of our technology.

Here's how our licensing model contributes to our financial sustainability:

1. Revenue from Licensing: We will negotiate licensing agreements with pharmaceutical companies, granting them the rights to utilize our solution within their operations. These agreements will involve a licensing fee structure that provides a recurring revenue stream for our organization.

2. Customization and Integration: We can offer customization and integration services to pharmaceutical companies, tailoring our solution to their specific needs and seamlessly integrating it with their existing infrastructure. This value-added service can generate additional revenue streams and create long-term partnerships.

3. Scalability and Expansion: By licensing our solution, we can scale our impact and expand our reach to a wider range of pharmaceutical companies globally. This opens up opportunities to generate revenue from multiple licensing agreements, ensuring financial sustainability and growth.

It's important to note that while licensing is a significant part of our financial sustainability plan, we may also explore other complementary revenue streams. These may include grant funding, strategic partnerships, or additional service contracts with governments or healthcare organizations that align with our mission.

By combining our licensing model with other revenue streams, we aim to establish a strong financial foundation that supports the long-term sustainability and growth of our organization. This allows us to continue driving positive impact in rare disease healthcare and advancing our solution to benefit patients, caregivers, and the broader healthcare ecosystem.

So far, I have received Rs. 10,00,000 (around USD 12,200)